Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
WRBY · against 350 other Healthcare companies of similar size
Ranked #242 of 351 · scores higher than 31% of peers
Bars: peers in each 10-point band of the valuation score30 peers with a valuation score of 30–39, including WRBY · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | WRBY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 343 reported | 0.3% | 2.3% | 35% | 30% | |
| EBITDA yieldHigher is better · 348 reported | 1.6% | 4.6% | 32% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | 0.8% | -0.0% | 54% | 20% | |
| Book yieldHigher is better · 343 reported | 14.0% | 32.1% | 20% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 236 | 1.6B USD | 38 | 33 | |
| 236 | 2.0B USD | 38 | 27 | |
| 242 | 12.7B CNY (≈$1.8B) | 37 | 20 | |
| 242 | 5.2B USD | 37 | 74 | |
| 242 | 2.7B USD | 37 | 44 | |
| 245 | 18.7B CNY (≈$2.6B) | 36 | 51 | |
| 245 | 1.2B CHF (≈$1.4B) | 36 | 34 | |
| 245 | 3.1B USD | 36 | 53 | |
| 245 | 1.9B USD | 36 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score